Skip to main content
Clinical Trials/JPRN-UMIN000035188
JPRN-UMIN000035188
Recruiting
N/A

Multicenter, prospective research on prevalence and fibrosis stage distribution in Japanese NAFLD patients using with ultrasound elastography [FibroScan] and Fib4 index - Multicenter, prospective research on prevalence and fibrosis stage distribution in Japanese NAFLD patients using with ultrasound elastography [FibroScan] and Fib4 index

Yokohama City University0 sites10,000 target enrollmentDecember 9, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Yokohama City University
Enrollment
10000
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 9, 2018
End Date
March 31, 2022
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Alcohol consumption (ethanol equivalent volume), \>\=30 g/day for men, \>\=20 g/day for women, or \>\=210 g/day for men, \>\=140 g/day for women. 2\. History of chronic hepatic disease (hemochromatosis, viral hepatic disease \[hepatitis B or C], or autoimmune disease,\[autoimmune hepatitis, primary biliary cholangitis]), thyroid disorder, lipoatrophy, parenteral nutrition, abetalipoproteinemia, alpha\-1\-antitrypsin deficiency, Wilson's disease, antiretroviral therapy, Reye's syndrome, HELLP syndrome, or inborn errors of metabolism (lecithin\-cholesterol acyltransferase deficiency or lysosomal acid lipase deficiency) 3\. Drug\-induced liver disorder (amiodarone, methotrexate, tamoxifen, corticosteroids, valproic acid, and antiretroviral drugs)

Outcomes

Primary Outcomes

Not specified

Similar Trials